Skip to main content
Clinical Trials/ACTRN12621000247875
ACTRN12621000247875
Recruiting
Phase 2

Resuscitation in Paediatric Sepsis using Vitamin C and Hydrocortisone - A Randomized Controlled Multicentre Trial - assessing the effect on time alive and free of vasopressors

The University of Queensland0 sites384 target enrollmentMarch 8, 2021

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Sepsis
Sponsor
The University of Queensland
Enrollment
384
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 8, 2021
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Criterion 1: Child aged \>\=7 days and \<18 years and admitted to PICU.
  • Criterion 2: Decision by treating physician to treat as sepsis (including parenteral antibiotics and inotropes)
  • Criterion 3: Treatment of septic shock with vasopressor/inotrope therapy for \>1 hour, or at a Vasopressor\-Inotrope\-Score of at least 10\.
  • Inotrope requirement will be calculated by means of the Vasoactive\-Inotrope Score (VIS)63: VIS \= dopamine dose (micgrogram/kg/min) \+ dobutamine dose (microgram/kg/min) \+ 100 x adrenaline dose (microgram/kg/min) \+ 100 x noradrenaline dose (microgram/kg/min) \+ 10 x milrinone dose (microgram/kg/min) \+ 10,000 x argipressin(vasopressin) dose (unit/kg/min). Note: vasopressin doses are often recorded as mU/kg/hour, which needs conversion to U/kg/min for the VIS score.

Exclusion Criteria

  • \- Preterm babies born \<34 weeks gestation that have a corrected age of \<7 days
  • \- Known chronic renal failure (defined as requiring continuous RRT prior to the onset of sepsis)
  • \- Palliative Care Patient/Patient with limitation of treatment (not for Inotropes, CPR, ECLS, Intubation and Ventilation)
  • \- Cardiopulmonary arrest in the past two hours requiring CPR \>2 min, or death is deemed to be imminent or inevitable
  • \- Patients with sepsis/septic shock who have been treated with inotropes for septic shock for \>24 hours
  • \- Patients with known glucose\-6 phosphate dehydrogenase (G\-6PD) deficiency
  • \- Patients with known history of oxalate nephropathy
  • \- Patients with known malaria
  • \- Enrolment in RESPOND study within the past 6 months

Outcomes

Primary Outcomes

Not specified

Similar Trials